Speaking at Cphi Japan 2023 (19-21), one keynote speaker – Ian Haydock, Editor-In-Chief, Insights, Asia-Pacific at Citeline – predicted that the continued rise of biopharma innovation in China is the Big Macro trend in the APAC region that could potentially lead to shifts in outsourcing and manufacturing strategies regionally. “Historically, we have seen a dual […]

The post CPHI Japan: the rise of Chinese innovation the big macro story for APAC in 2023 first appeared on World Pharma Today.